VIR logo

Vir Biotechnology (VIR) Company Overview

Profile

Full Name:

Vir Biotechnology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 11, 2019

Indexes:

Not included

Description:

Vir Biotechnology, Inc. is an American clinical immunology company. Registered in 2016 in the state of Delaware. Headquarters are located in San Francisco, California. The company specializes in developing methods based on a combination of immune responses and advanced technologies for the treatment and prevention of serious diseases such as hepatitis B or HBV, influenza A, severe acute respiratory syndrome, coronavirus 2 or SARS-CoV-2, human immunodeficiency virus or HIV, and tuberculosis. Drug candidates are developed on four technological platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or miRNA, through internal development, collaborations, and acquisitions.

Events Calendar

Earnings

Next earnings date:

Feb 26, 2025

Recent quarterly earnings:

Oct 31, 2024

Recent annual earnings:

Feb 22, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 31, 25 HC Wainwright & Co.
Buy
Jan 13, 25 Leerink Partners
Outperform
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 9, 25 Morgan Stanley
Overweight
Jan 9, 25 JP Morgan
Neutral
Nov 20, 24 Needham
Buy
Nov 20, 24 HC Wainwright & Co.
Buy
Nov 4, 24 HC Wainwright & Co.
Buy
Nov 4, 24 Barclays
Overweight
Nov 1, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Vir Biotechnology?
  • Does Vir Biotechnology pay dividends?
  • What sector is Vir Biotechnology in?
  • What industry is Vir Biotechnology in?
  • What country is Vir Biotechnology based in?
  • When did Vir Biotechnology go public?
  • Is Vir Biotechnology in the S&P 500?
  • Is Vir Biotechnology in the NASDAQ 100?
  • Is Vir Biotechnology in the Dow Jones?
  • When was Vir Biotechnology's last earnings report?
  • When does Vir Biotechnology report earnings?
  • Should I buy Vir Biotechnology stock now?

What is the ticker symbol for Vir Biotechnology?

The ticker symbol for Vir Biotechnology is NASDAQ:VIR

Does Vir Biotechnology pay dividends?

No, Vir Biotechnology does not pay dividends

What sector is Vir Biotechnology in?

Vir Biotechnology is in the Healthcare sector

What industry is Vir Biotechnology in?

Vir Biotechnology is in the Biotechnology industry

What country is Vir Biotechnology based in?

Vir Biotechnology is headquartered in United States

When did Vir Biotechnology go public?

Vir Biotechnology's initial public offering (IPO) was on October 11, 2019

Is Vir Biotechnology in the S&P 500?

No, Vir Biotechnology is not included in the S&P 500 index

Is Vir Biotechnology in the NASDAQ 100?

No, Vir Biotechnology is not included in the NASDAQ 100 index

Is Vir Biotechnology in the Dow Jones?

No, Vir Biotechnology is not included in the Dow Jones index

When was Vir Biotechnology's last earnings report?

Vir Biotechnology's most recent earnings report was on Oct 31, 2024

When does Vir Biotechnology report earnings?

The next expected earnings date for Vir Biotechnology is Feb 26, 2025

Should I buy Vir Biotechnology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions